• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级医疗中心帕金森病非运动症状表现的探索:一项综合分析

Exploring the Manifestation of Non-motor Symptoms in Parkinson's Disease in a Tertiary Care Center: A Comprehensive Analysis.

作者信息

Gonaboyina Deepak S, Das Pragateshnu, Pradhan Nikhilesh, Dash Prerana, Venugopalan Vipin, Dash Santosh

机构信息

Department of Neurology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

出版信息

Cureus. 2025 Jul 9;17(7):e87633. doi: 10.7759/cureus.87633. eCollection 2025 Jul.

DOI:10.7759/cureus.87633
PMID:40641497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12244841/
Abstract

BACKGROUND

Non-motor symptoms (NMS) in Parkinson's disease (PD) can influence cognition, emotion, sleep, and autonomic systems. NMS frequently precede motor symptoms, underscoring the necessity for a thorough comprehension of these symptoms, especially in heterogeneous populations like India. This study aims to explore the NMS of PD in a cohort from eastern India.

MATERIALS AND METHODS

Sixty consecutive patients with PD were enrolled in this study after considering the inclusion and exclusion criteria. Informed consent was obtained from each patient after ethical clearance from the institutional ethics committee. Data were collected by using the standardized Movement Disorder Society Non-Motor Symptoms Rating Scale (MDS-NMS) to assess various NMS. Additionally, the study categorized patients into clinical subtypes based on their predominant symptoms and it analyzed how NMS manifested in each subtype. The correlation between NMS was also assessed.

RESULT

Gastrointestinal (GI) issues were the most common NMS, affecting all 60 (100%) patients. Depression affected 59 (98.33%) patients, followed by anxiety in 57 (95%) patients. Only two (3.33%) patients reported sexual dysfunction, while 55 (91.67%) patients reported pain, and 54 (90%) patients reported cognitive impairment. Constipation was more common among symptoms of the GI domain. Twenty-seven (45%) patients had developed at least one NMS prior to the diagnosis of PD. Younger patients (<60 years) tend to experience more severe emotional symptoms like depression and anxiety. Older patients (60-80 years) showed increasing severity of physical symptoms like pain, fatigue, and GI issues, along with cognitive decline. No statistically significant differences were observed for NMS severity between the akinetic-rigid versus tremor-predominant subtypes of PD.

CONCLUSION

The findings emphasize that NMS are prevalent in nearly all PD patients. Addressing NMS in clinical practice is crucial for improving patient outcomes. Particularly in India, where these symptoms may be underdiagnosed, the study highlights the need for routine screening and management of NMS to enhance overall care strategies for PD patients.

摘要

背景

帕金森病(PD)中的非运动症状(NMS)可影响认知、情绪、睡眠和自主神经系统。NMS常先于运动症状出现,这凸显了全面了解这些症状的必要性,尤其是在印度这样的异质人群中。本研究旨在探索印度东部一个队列中PD的NMS。

材料与方法

在考虑纳入和排除标准后,连续纳入60例PD患者。经机构伦理委员会伦理批准后,获得了每位患者的知情同意。使用标准化的运动障碍协会非运动症状评定量表(MDS-NMS)收集数据,以评估各种NMS。此外,该研究根据患者的主要症状将其分为临床亚型,并分析了每种亚型中NMS的表现形式。还评估了NMS之间的相关性。

结果

胃肠道(GI)问题是最常见的NMS,影响了所有60例(100%)患者。抑郁影响了59例(98.33%)患者,其次是焦虑,有57例(95%)患者。只有2例(3.33%)患者报告有性功能障碍,而55例(91.67%)患者报告有疼痛,54例(90%)患者报告有认知障碍。便秘在GI领域症状中更为常见。27例(45%)患者在PD诊断之前就已出现至少一种NMS。年轻患者(<60岁)往往经历更严重的情绪症状,如抑郁和焦虑。老年患者(60 - 80岁)身体症状如疼痛、疲劳和GI问题的严重程度增加,同时伴有认知能力下降。在PD的运动不能-强直型与震颤为主型亚型之间,未观察到NMS严重程度的统计学显著差异。

结论

研究结果强调NMS在几乎所有PD患者中都很普遍。在临床实践中处理NMS对于改善患者预后至关重要。特别是在印度,这些症状可能未得到充分诊断,该研究强调了对NMS进行常规筛查和管理的必要性,以加强PD患者的整体护理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/5c587a10694f/cureus-0017-00000087633-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/98bd01744223/cureus-0017-00000087633-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/bc5de685f770/cureus-0017-00000087633-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/593131a2c1f9/cureus-0017-00000087633-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/97b2ca112417/cureus-0017-00000087633-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/832489a48285/cureus-0017-00000087633-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/26b38a63adeb/cureus-0017-00000087633-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/5c587a10694f/cureus-0017-00000087633-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/98bd01744223/cureus-0017-00000087633-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/bc5de685f770/cureus-0017-00000087633-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/593131a2c1f9/cureus-0017-00000087633-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/97b2ca112417/cureus-0017-00000087633-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/832489a48285/cureus-0017-00000087633-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/26b38a63adeb/cureus-0017-00000087633-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b71/12244841/5c587a10694f/cureus-0017-00000087633-i07.jpg

相似文献

1
Exploring the Manifestation of Non-motor Symptoms in Parkinson's Disease in a Tertiary Care Center: A Comprehensive Analysis.三级医疗中心帕金森病非运动症状表现的探索:一项综合分析
Cureus. 2025 Jul 9;17(7):e87633. doi: 10.7759/cureus.87633. eCollection 2025 Jul.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.对于帕金森病患者,在接受丘脑底核刺激后,抑郁症状会对患者报告的疾病严重程度产生负面影响。
J Parkinsons Dis. 2025 Jun 26:1877718X251354933. doi: 10.1177/1877718X251354933.
5
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).静脉注射脂质体GM1治疗帕金森病患者的安全性和耐受性:一项单中心开放标签的I期临床试验(NEON试验)。
PLoS Med. 2025 May 13;22(5):e1004472. doi: 10.1371/journal.pmed.1004472. eCollection 2025 May.
6
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
7
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.成人伴或不伴有广场恐惧症的惊恐障碍的心理治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 Apr 13;4(4):CD011004. doi: 10.1002/14651858.CD011004.pub2.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
Management of faecal incontinence and constipation in adults with central neurological diseases.成人中枢神经系统疾病患者大便失禁和便秘的管理
Cochrane Database Syst Rev. 2013 Dec 18(12):CD002115. doi: 10.1002/14651858.CD002115.pub4.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

本文引用的文献

1
Assessment of Non-Motor Symptoms of Parkinson's Disease and Their Impact on the Quality of Life: An Observatiobnal Study.帕金森病非运动症状评估及其对生活质量的影响:一项观察性研究。
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):909-915. doi: 10.4103/aian.aian_647_21. Epub 2022 Aug 4.
2
Olfactory impairment as an early marker of Parkinson's disease in REM sleep behaviour disorder: a systematic review and meta-analysis.嗅觉障碍作为 REM 睡眠行为障碍中帕金森病的早期标志物:系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):271-281. doi: 10.1136/jnnp-2020-325361. Epub 2021 Jan 12.
3
Prevalence of Non-motor Symptoms in Parkinson's Disease and Its Impact on Quality of Life in Tertiary Care Center in India.
印度三级医疗中心帕金森病非运动症状的患病率及其对生活质量的影响。
Ann Indian Acad Neurol. 2020 May-Jun;23(3):270-274. doi: 10.4103/aian.AIAN_10_19. Epub 2020 Jun 10.
4
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
5
Nonmotor Parkinson's and Future Directions.非运动型帕金森病及未来发展方向。
Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4.
6
Treatment of Nonmotor Symptoms in Parkinson's Disease.帕金森病非运动症状的治疗
Int Rev Neurobiol. 2017;132:361-379. doi: 10.1016/bs.irn.2017.03.002. Epub 2017 May 3.
7
Parkinson disease.帕金森病。
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
8
Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.帕金森病中的胃肠功能障碍:症状与治疗
Parkinsons Dis. 2016;2016:6762528. doi: 10.1155/2016/6762528. Epub 2016 Dec 6.
9
Cognitive impairment in idiopathic Parkinson's disease.特发性帕金森病中的认知障碍
Neurol India. 2016 May-Jun;64(3):419-27. doi: 10.4103/0028-3886.181533.
10
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.